ESC2024冠状动脉疾病诊疗指南（全文）英文版ESC2024CoronaryArteryDiseaseDiagnosisandTreatmentGuidelines(FullText)Introduction:Coronaryarterydisease(CAD)isaleadingcauseofmorbidityandmortalityworldwide.EarlydiagnosisandappropriatetreatmentarecrucialinmanagingCAD.TheESC2024guidelinesaimtoproviderecommendationsforthediagnosisandtreatmentofCAD.RiskFactors:RiskfactorsforCADincludehypertension,diabetes,smoking,obesity,andfamilyhistoryofCAD.ThesefactorsshouldbeassessedinallpatientspresentingwithsymptomssuggestiveofCAD.Diagnosis:ThediagnosisofCADisbasedonclinicalhistory,physicalexamination,anddiagnostictestssuchaselectrocardiogram(ECG),stresstesting,andcoronaryangiography.Non-invasiveimagingmodalitieslikeCTcoronaryangiographycanalsobeusedfordiagnosis.Treatment:ThetreatmentofCADincludeslifestylemodifications,pharmacologicaltherapy,andinvasiveprocedureslikepercutaneouscoronaryintervention(PCI)andcoronaryarterybypassgrafting(CABG).Antiplateletagents,statins,beta-blockers,andangiotensin-convertingenzymeinhibitorsarecommonlyusedmedicationsinthemanagementofCAD.SecondaryPrevention:SecondarypreventionstrategiesforCADfocusonlifestylemodification,riskfactorcontrol,andmedicationadherence.Cardiacrehabilitationprogramsandregularfollow-upvisitsareessentialforlong-termmanagementofCAD.Conclusion:TheESC2024guidelinesprovideevidence-basedrecommendationsforthediagnosisandtreatmentofCAD.Earlydiagnosis,riskfactorassessment,andappropriatemanagementarekeytoimprovingoutcomesinpatientswithCAD.Reference:EuropeanSocietyofCardiology.ESC2024CoronaryArteryDiseaseDiagnosisandTreatmentGuidelines.Availableat:[linktoofficialESCwebsite](Note:ThisisafictionaldocumentanddoesnotrepresentactualESCguidelines)